查看購物車
  • English
封面
市場調查報告書
商品編碼
1905148

日本敗血症診斷市場報告（按診斷、產品、檢測方式、技術、病原體、最終用戶和地區分類，2026-2034年）

Japan Sepsis Diagnostics Market Report by Diagnosis, Product, Mode of Testing, Technology, Pathogen, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 122 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2025年，日本膿毒症診斷市場規模達2,580萬美元。展望未來， IMARC Group預計到2034年，該市場規模將達到4,890萬美元，2026年至2034年間的複合年成長率（CAGR）為7.36%。推動市場成長的主要因素是先進資料分析工具的日益普及，這些工具通常能夠整合來自不同平台的多項檢測結果，從而提供即時資料存取和精準的疾病診斷。

本報告解答的關鍵問題

  • 1.日本敗血症診斷市場規模有多大？
  • 2.日本敗血症診斷市場前景如何？
  • 3.哪些因素正在推動日本膿毒症診斷市場的成長？

目錄

第1章：序言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 數據來源
  • 市場估算
  • 預測方法

第3章：執行概要

第4章：日本膿毒症診斷市場－簡介

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭情報

第5章：日本敗血症診斷市場概況

  • 歷史及當前市場趨勢（2020-2025）
  • 市場預測（2026-2034）

第6章：日本敗血症診斷市場－依診斷類型分類

  • 自動化診斷
  • 傳統診斷

第7章：日本敗血症診斷市場－依產品細分

  • 儀器
  • 檢測試劑盒和試劑
  • 血液培養基
  • 軟體

第8章：日本膿毒症診斷市場－依檢測方式分類

  • 實驗室檢測
  • 即時檢測

第9章：日本膿毒症診斷市場－依技術分類

  • 分子診斷
  • 免疫測定
  • 生物標記
  • 流式細胞儀
  • 微流控技術
  • 血液培養

第10章：日本膿毒症診斷市場－按病原體分類

  • 細菌性敗血症
  • 病毒性敗血症
  • 黴菌性敗血症
  • 其他

第11章：日本膿毒症診斷市場－以最終用戶分類

  • 診斷診所
  • 醫院
  • 研究實驗室

第12章：日本膿毒症診斷市場－按地區分類

  • 關東地區
  • 關西/近畿地區
  • 中部/中部地區
  • 九州·沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第13章：日本敗血症診斷市場－競爭格局

  • 概述
  • 市場結構
  • 市場參與者定位
  • 最佳制勝策略
  • 競爭格局分析
  • 公司評估象限

第14章：關鍵參與者簡介

第15章：日本膿毒症診斷市場－產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第16章：附錄

簡介目錄
Product Code: SR112026A18716

Japan sepsis diagnostics market size reached USD 25.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 48.9 Million by 2034, exhibiting a growth rate (CAGR) of 7.36% during 2026-2034. The increasing adoption of advanced data analytics tools that generally enable the integration of multiple test results from different platforms to offer real-time data access and accurate disease diagnosis is primarily driving the market growth.

Sepsis is a medical condition that arises as a response of the body when it attempts to combat infections caused by the presence of bacteria, viruses, or fungi. In this state, the immune system releases various chemicals into the bloodstream, setting off excessive inflammation and the formation of blood clots throughout the body. Sepsis can lead to the failure of multiple organs, irregular breathing, low blood pressure, neurological dysfunction, an elevated heart rate, and more. The diagnostic methods for detecting sepsis primarily encompass molecular diagnosis, immunoassays, microfluidics, biomarkers, flow cytometry, and similar technologies. These diagnostic techniques see widespread use in various healthcare settings, including hospitals, pathology laboratories, reference laboratories, and academic research institutions, among others.

Japan Sepsis Diagnostics Market Trends:

In the Japanese market, the surge in demand for sepsis diagnostics can be attributed to several key factors. Firstly, there is a noticeable increase in hospital-acquired infections (HAIs) that can lead to sepsis, particularly among vulnerable demographic groups such as the elderly, infants, and patients with chronic ailments. This trend is a driving force behind the need for improved sepsis diagnostic tools. Secondly, the growing instances of infectious diseases caused by antibiotic-resistant bacteria, including both gram-positive bacteria and gram-negative bacilli, are contributing to the heightened demand for sepsis diagnostics in Japan. These antibiotic-resistant strains require accurate and timely diagnosis for effective treatment. Furthermore, Japan's expanding healthcare sector, coupled with the widespread adoption of advanced data analytics tools, is playing a significant role in catalyzing the growth of the sepsis diagnostics market. These tools enable the integration of diverse test results from various platforms, offering real-time access to critical data and precise disease diagnosis. Additionally, continuous technological advancements have led to the development of new immunological and molecular biomarkers, facilitating early sepsis detection. Investment in extensive research and development activities, including innovative blood culture methods for identifying and managing chronic infections, is expected to contribute to the expansion of the sepsis diagnostics market in Japan over the forecasted period.

Japan Sepsis Diagnostics Market Segmentation:

Diagnosis Insights:

  • Automated Diagnostics
  • Conventional Diagnostics

Product Insights:

  • Instruments
  • Assay Kits and Reagents
  • Blood Culture Media
  • Software

Mode of Testing Insights:

  • Laboratory Tests
  • Point-of-Care Tests

Technology Insights:

  • Molecular Diagnostics
  • Immunoassays
  • Biomarkers
  • Flow Cytometry
  • Microfluidics
  • Blood Culture

Pathogen Insights:

  • Bacterial Sepsis
    • Gram-Positive Bacterial Sepsis
    • Gram-Negative Bacterial Sepsis
  • Viral Sepsis
  • Fungal Sepsis
  • Others

End User Insights:

  • Diagnostic Clinics
  • Hospitals
  • Research Laboratories

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report

  • 1.How big is the sepsis diagnostics market in Japan?
  • 2.What is the forecast for the sepsis diagnostics market in Japan?
  • 3.What factors are driving the growth of the Japan sepsis diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Sepsis Diagnostics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Sepsis Diagnostics Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Sepsis Diagnostics Market - Breakup by Diagnosis

  • 6.1 Automated Diagnostics
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Conventional Diagnostics
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)

7 Japan Sepsis Diagnostics Market - Breakup by Product

  • 7.1 Instruments
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Assay Kits and Reagents
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Blood Culture Media
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Software
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)

8 Japan Sepsis Diagnostics Market - Breakup by Mode of Testing

  • 8.1 Laboratory Tests
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Point-of-Care Tests
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)

9 Japan Sepsis Diagnostics Market - Breakup by Technology

  • 9.1 Molecular Diagnostics
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Immunoassays
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)
  • 9.3 Biomarkers
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Forecast (2026-2034)
  • 9.4 Flow Cytometry
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Forecast (2026-2034)
  • 9.5 Microfluidics
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Forecast (2026-2034)
  • 9.6 Blood Culture
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Forecast (2026-2034)

10 Japan Sepsis Diagnostics Market - Breakup by Pathogen

  • 10.1 Bacterial Sepsis
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Segmentation
      • 10.1.3.1 Gram-Positive Bacterial Sepsis
      • 10.1.3.2 Gram-Negative Bacterial Sepsis
    • 10.1.4 Market Forecast (2026-2034)
  • 10.2 Viral Sepsis
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Forecast (2026-2034)
  • 10.3 Fungal Sepsis
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Forecast (2026-2034)
  • 10.4 Others
    • 10.4.1 Historical and Current Market Trends (2020-2025)
    • 10.4.2 Market Forecast (2026-2034)

11 Japan Sepsis Diagnostics Market - Breakup by End User

  • 11.1 Diagnostic Clinics
    • 11.1.1 Overview
    • 11.1.2 Historical and Current Market Trends (2020-2025)
    • 11.1.3 Market Forecast (2026-2034)
  • 11.2 Hospitals
    • 11.2.1 Overview
    • 11.2.2 Historical and Current Market Trends (2020-2025)
    • 11.2.3 Market Forecast (2026-2034)
  • 11.3 Research Laboratories
    • 11.3.1 Overview
    • 11.3.2 Historical and Current Market Trends (2020-2025)
    • 11.3.3 Market Forecast (2026-2034)

12 Japan Sepsis Diagnostics Market - Breakup by Region

  • 12.1 Kanto Region
    • 12.1.1 Overview
    • 12.1.2 Historical and Current Market Trends (2020-2025)
    • 12.1.3 Market Breakup by Diagnosis
    • 12.1.4 Market Breakup by Product
    • 12.1.5 Market Breakup by Mode of Testing
    • 12.1.6 Market Breakup by Technology
    • 12.1.7 Market Breakup by Pathogen
    • 12.1.8 Market Breakup by End User
    • 12.1.9 Key Players
    • 12.1.10 Market Forecast (2026-2034)
  • 12.2 Kansai/Kinki Region
    • 12.2.1 Overview
    • 12.2.2 Historical and Current Market Trends (2020-2025)
    • 12.2.3 Market Breakup by Diagnosis
    • 12.2.4 Market Breakup by Product
    • 12.2.5 Market Breakup by Mode of Testing
    • 12.2.6 Market Breakup by Technology
    • 12.2.7 Market Breakup by Pathogen
    • 12.2.8 Market Breakup by End User
    • 12.2.9 Key Players
    • 12.2.10 Market Forecast (2026-2034)
  • 12.3 Central/ Chubu Region
    • 12.3.1 Overview
    • 12.3.2 Historical and Current Market Trends (2020-2025)
    • 12.3.3 Market Breakup by Diagnosis
    • 12.3.4 Market Breakup by Product
    • 12.3.5 Market Breakup by Mode of Testing
    • 12.3.6 Market Breakup by Technology
    • 12.3.7 Market Breakup by Pathogen
    • 12.3.8 Market Breakup by End User
    • 12.3.9 Key Players
    • 12.3.10 Market Forecast (2026-2034)
  • 12.4 Kyushu-Okinawa Region
    • 12.4.1 Overview
    • 12.4.2 Historical and Current Market Trends (2020-2025)
    • 12.4.3 Market Breakup by Diagnosis
    • 12.4.4 Market Breakup by Product
    • 12.4.5 Market Breakup by Mode of Testing
    • 12.4.6 Market Breakup by Technology
    • 12.4.7 Market Breakup by Pathogen
    • 12.4.8 Market Breakup by End User
    • 12.4.9 Key Players
    • 12.4.10 Market Forecast (2026-2034)
  • 12.5 Tohoku Region
    • 12.5.1 Overview
    • 12.5.2 Historical and Current Market Trends (2020-2025)
    • 12.5.3 Market Breakup by Diagnosis
    • 12.5.4 Market Breakup by Product
    • 12.5.5 Market Breakup by Mode of Testing
    • 12.5.6 Market Breakup by Technology
    • 12.5.7 Market Breakup by Pathogen
    • 12.5.8 Market Breakup by End User
    • 12.5.9 Key Players
    • 12.5.10 Market Forecast (2026-2034)
  • 12.6 Chugoku Region
    • 12.6.1 Overview
    • 12.6.2 Historical and Current Market Trends (2020-2025)
    • 12.6.3 Market Breakup by Diagnosis
    • 12.6.4 Market Breakup by Product
    • 12.6.5 Market Breakup by Mode of Testing
    • 12.6.6 Market Breakup by Technology
    • 12.6.7 Market Breakup by Pathogen
    • 12.6.8 Market Breakup by End User
    • 12.6.9 Key Players
    • 12.6.10 Market Forecast (2026-2034)
  • 12.7 Hokkaido Region
    • 12.7.1 Overview
    • 12.7.2 Historical and Current Market Trends (2020-2025)
    • 12.7.3 Market Breakup by Diagnosis
    • 12.7.4 Market Breakup by Product
    • 12.7.5 Market Breakup by Mode of Testing
    • 12.7.6 Market Breakup by Technology
    • 12.7.7 Market Breakup by Pathogen
    • 12.7.8 Market Breakup by End User
    • 12.7.9 Key Players
    • 12.7.10 Market Forecast (2026-2034)
  • 12.8 Shikoku Region
    • 12.8.1 Overview
    • 12.8.2 Historical and Current Market Trends (2020-2025)
    • 12.8.3 Market Breakup by Diagnosis
    • 12.8.4 Market Breakup by Product
    • 12.8.5 Market Breakup by Mode of Testing
    • 12.8.6 Market Breakup by Technology
    • 12.8.7 Market Breakup by Pathogen
    • 12.8.8 Market Breakup by End User
    • 12.8.9 Key Players
    • 12.8.10 Market Forecast (2026-2034)

13 Japan Sepsis Diagnostics Market - Competitive Landscape

  • 13.1 Overview
  • 13.2 Market Structure
  • 13.3 Market Player Positioning
  • 13.4 Top Winning Strategies
  • 13.5 Competitive Dashboard
  • 13.6 Company Evaluation Quadrant

14 Profiles of Key Players

  • 14.1 Company A
    • 14.1.1 Business Overview
    • 14.1.2 Services Offered
    • 14.1.3 Business Strategies
    • 14.1.4 SWOT Analysis
    • 14.1.5 Major News and Events
  • 14.2 Company B
    • 14.2.1 Business Overview
    • 14.2.2 Services Offered
    • 14.2.3 Business Strategies
    • 14.2.4 SWOT Analysis
    • 14.2.5 Major News and Events
  • 14.3 Company C
    • 14.3.1 Business Overview
    • 14.3.2 Services Offered
    • 14.3.3 Business Strategies
    • 14.3.4 SWOT Analysis
    • 14.3.5 Major News and Events
  • 14.4 Company D
    • 14.4.1 Business Overview
    • 14.4.2 Services Offered
    • 14.4.3 Business Strategies
    • 14.4.4 SWOT Analysis
    • 14.4.5 Major News and Events
  • 14.5 Company E
    • 14.5.1 Business Overview
    • 14.5.2 Services Offered
    • 14.5.3 Business Strategies
    • 14.5.4 SWOT Analysis
    • 14.5.5 Major News and Events

15 Japan Sepsis Diagnostics Market - Industry Analysis

  • 15.1 Drivers, Restraints, and Opportunities
    • 15.1.1 Overview
    • 15.1.2 Drivers
    • 15.1.3 Restraints
    • 15.1.4 Opportunities
  • 15.2 Porters Five Forces Analysis
    • 15.2.1 Overview
    • 15.2.2 Bargaining Power of Buyers
    • 15.2.3 Bargaining Power of Suppliers
    • 15.2.4 Degree of Competition
    • 15.2.5 Threat of New Entrants
    • 15.2.6 Threat of Substitutes
  • 15.3 Value Chain Analysis

16 Appendix